Tuesday, October 11, 2022

BioLineRx Announces Submission of New Drug Application (NDA) to FDA for Motixafortide in Stem Cell Mobilization

›
BioLineRx Ltd.  announced the  submission of  its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Motixafortid...
Monday, October 10, 2022

Cidara Therapeutics Announces FDA Acceptance for Priority Review of New Drug Application for Rezafungin for the Treatment of Candidemia and Invasive Candidiasis

›
Cidara Therapeutics, Inc.  , a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patien...
Friday, October 7, 2022

Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

›
The researchers developed three different computer models to predict how a hypothetical set of 10,000 patients with specific types of metast...
Thursday, October 6, 2022

Drug turns cancer gene into 'eat me' flag for immune system

›
Sotorasib The new therapy, described Sept. 12 in  Cell Cancer , pulls a mutated version of the protein KRAS to the surface of cancer cells, ...
Wednesday, October 5, 2022

Smoking May Increase Odds of Meniere Disease in Men

›
For men, smoking is positively related and alcohol consumption is negatively related to the risk for Meniere disease (MD), according to a st...
Tuesday, October 4, 2022

Daily Multivitamin May Protect Against Cognitive Decline in Older Adults

›
In continuation of my update on Vitamin and their importance  A daily multivitamin may provide cognitive benefits for older adults, accordi...
Monday, October 3, 2022

FDA Approves Zoryve (roflumilast) Cream for the Treatment of Plaque Psoriasis

›
      Arcutis Biotherapeutics, Inc.   an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...
Friday, September 30, 2022

FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults

›
            dextromethorphan   Bupropion In continuation of my updates on dextromethorphan and Bupropion ,  Axsome Therapeutics, Inc. , a...
Thursday, September 29, 2022

FDA Approves Konvomep (omeprazole and sodium bicarbonate for oral suspension) for Gastric Ulcer and Reduction of Risk of Gastrointestinal Bleeding in Critically Ill Patients

›
     In continuation of my update on omeprazole Azurity Pharmaceuticals, Inc., a pharmaceutical company focused on developing innovative do...
Monday, September 26, 2022

FDA Approves Sotyktu (deucravacitinib) for the Treatment of Adults with Moderate-to-Severe Plaque Psoriasis

›
  Bristol Myers Squibb (NYSE: BMY)   announced   the U.S. Food and Drug Administration (FDA) approval of  Sotyktu ™ (deucravacitinib), a fi...
Friday, September 23, 2022

FDA Approves Terlivaz (terlipressin) for the Treatment of Hepatorenal Syndrome (HRS)

›
Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company,   announced  the U.S. Food and Drug Administration (FDA) ap...
Thursday, September 22, 2022

FDA Approves Aponvie (aprepitant) for the Prevention of Postoperative Nausea and Vomiting (PONV)

›
In continuation of my update on aprepitant       Heron Therapeutics, Inc., a commercial-stage biotechnology company focused on improving t...